Ultrasound may not be as cutting-edge as, say, nuclear imaging or pack the punch of CT, but the technology that’s now more than a century old is making a comeback in unexpected avenues.

Researchers may be closer to detecting cancers before symptoms become apparent in patients, according to a recent article by NPR. Although more research needs to be conducted, the newly developed non-invasive blood test would detect eight common types of cancer, with the potential to open up possibilities in the field of oncology.  

As life expectancy continues to expand for cancer patients, clinicians are increasingly dealing with oncological complications like cardiotoxicity, according to a medical team in the Netherlands—and those doctors are met with a paucity of research on the topic.

New appropriateness criteria created to get patients more involved in their own care have been released today, online in the Journal of the American College of Radiology.

GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop and co-market digital clinical decision support solutions. The partnership will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.

Researchers have developed a new MRI technology that allows patients with suspected kidney tumors to bypass biopsies. A recent study, led by Ivan Pedrosa, MD and Jeffrey Cadeddu, MD with the Kidney Cancer Program at the University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, was published online Jan. 2 in The Journal of Urology.

Radiologists and health imaging specialists trust in technology—improvements in image quality, efficiency and costs will likely continue. But the methods of cancer detection may be no match for individual health decisions.

A group of researchers under the leadership of Daniel Vigneron, PhD, at the University of California San Fransisco's Department of Radiology and Biomedical Imaging are in the in the process of developing hyperpolarized MRI techniques to detect, label, and target brain and prostate tumors.